RAPT Therapeutics/ US75382E1091 /
2024-06-24 9:59:55 PM | Chg. +0.08 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
3.24USD | +2.53% | 3,627 Turnover: 11,754.40 |
-Bid Size: - | -Ask Size: - | 3.33 | 3.17 |
GlobeNewswire
05-09
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RAPT Therapeut...
GlobeNewswire
04-09
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with...
GlobeNewswire
03-12
RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT S...
GlobeNewswire
03-07
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire
03-05
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Associatio...
GlobeNewswire
02-28
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire
02-21
RAPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claim...
GlobeNewswire
02-21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire
02-20
Investigation of RAPT Therapeutics, Inc. (RAPT) Announced by Holzer & Holzer, LLC
GlobeNewswire
02-13
RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vic...
GlobeNewswire
01-31
RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Confere...
GlobeNewswire
01-02
RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-11-27
RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Tre...
GlobeNewswire
2023-11-03
RAPT Therapeutics Announces Positive Data, Including Objective Response Rates and Progression-Free S...
GlobeNewswire
2023-11-01
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in November
GlobeNewswire
2023-10-18
RAPT Therapeutics Announces Two FLX475 Presentations at the Society for Immunotherapy of Cancer (SIT...
GlobeNewswire
2023-08-30
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September
GlobeNewswire
2022-03-28
RAPT Therapeutics Announces Biomarker Data from Phase 1b Trial of RPT193 Consistent with Disease Mod...
GlobeNewswire
2022-03-10
RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results
GlobeNewswire
2022-02-15
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
GlobeNewswire
2022-02-09
RAPT Therapeutics to Participate in the 11th Annual SVB Leerink Healthcare Conference